Search Results - "Bruckner, H.W."

Irinotecan Combined with Gemcitabine, 5‐Fluorouracil, Leucovorin, and Cisplatin (G‐FLIP) is an Effective and Noncrossresistant Treatment for Chemotherapy Refractory Metastatic Pancreatic Cancer by Kozuch, Peter, Grossbard, Michael L., Barzdins, Atis, Araneo, Miguel, Robin, Abigail, Frager, David, Homel, Peter, Marino, Jennifer, DeGregorio, Paola, Bruckner, H.W.

“…Background. Single agents have only modest activity as treatment for metastatic pancreatic cancer with response rates of less than 10% and median survivals of…”
Get full text

MODERATE DOSE SEQUENTIAL CHEMOTHERAPY (CT) ALGORITHMS (ALGOS) FOR THE ELDERLY WITH AND WITHOUT RESISTANT CANCERS (R-C) by Bruckner, H.W., Hirschfeld, A., De Jager, R., Bassali, F., Gurell, D., Nghiem, V., Book, A., Distenfeld, S., Weinberger, N.

Get full text

P016 - MODERATE DOSE SEQUENTIAL CHEMOTHERAPY (CT) ALGORITHMS (ALGOS) FOR THE ELDERLY WITH AND WITHOUT RESISTANT CANCERS (R-C) by Bruckner, H.W., Hirschfeld, A., De Jager, R., Bassali, F., Gurell, D., Nghiem, V., Book, A., Distenfeld, S., Weinberger, N.

Get full text

P032 - MODERATE SEQUENTIAL THIRD- TO FOURTH-LINE CHEMOTHERAPY (CT) ALGORITHMS (ALGO) FOR THE ELDERLY WITH RESISTANT COLORECTAL CANCER (R-CRC) by De Jager, R., Bruckner, H.W., Hirschfeld, A., Gurell, D., Nghiem, V., Book, A., Distenfeld, S., Weinberger, N.

Get full text

MODERATE SEQUENTIAL THIRD- TO FOURTH-LINE CHEMOTHERAPY (CT) ALGORITHMS (ALGO) FOR THE ELDERLY WITH RESISTANT COLORECTAL CANCER (R-CRC) by De Jager, R., Bruckner, H.W., Hirschfeld, A., Gurell, D., Nghiem, V., Book, A., Distenfeld, S., Weinberger, N.

Get full text

High-dose platinum for the treatment of refractory ovarian cancer by Bruckner, H W, Wallach, R, Cohen, C J, Deppe, G, Kabakow, B, Ratner, L, Holland, J F

Get more information

Chemotherapeutic Management of Small Bowel Adenocarcinoma Associated with Crohn's Disease by Bruckner, H.W., Hrehorovich, V.R, Sawhney, H.S., Meeus, S.I, Coopeman, A.M.

“…Four patients with metastatic primary small bowel adenocarcinoma associated with Crohn's disease were successfully treated with low dose combination…”
Get full text

Dose response in primary ovarian cancer evaluated by an ex vivo ATP chemosensitivity assay by Kurbacher, C.M., Munsch, S., Brenne, U., Gilster, T., Mallmann, P., Bruckner, H.W.

Get full text

Treatment of chemotherapy-resistant advanced ovarian cancer with a combination of cyclophosphamide, hexamethylmelamine, adriamycin, and cis-diamminedichloroplatinum (CHAP) by Bruckner, H W, Cohen, C J, Deppe, G, Kabakow, B, Wallach, R, Ratner, L, Holland, J F

Get more information